Literature DB >> 25289563

Core-shell nanoparticles based on pullulan and poly(β-amino) ester for hepatoma-targeted codelivery of gene and chemotherapy agent.

Yuanyuan Liu1, Yan Wang, Cong Zhang, Ping Zhou, Yang Liu, Tong An, Duxin Sun, Ning Zhang, Yinsong Wang.   

Abstract

This study designs a novel nanoparticle system with core-shell structure based on pullulan and poly(β-amino) ester (PBAE) for the hepatoma-targeted codelivery of gene and chemotherapy agent. Plasmid DNA expressing green fluorescent protein (pEGFP), as a model gene, was fully condensed with cationic PBAE to form the inner core of PBAE/pEGFP polycomplex. Methotrexate (MTX), as a model chemotherapy agent, was conjugated to pullulan by ester bond to synthesize polymeric prodrug of MTX-PL. MTX-PL was then adsorbed on the surface of PBAE/pEGFP polycomplex to form MTX-PL/PBAE/pEGFP nanoparticles with a classic core-shell structure. MTX-PL was also used as a hepatoma targeting moiety, because of its specific binding affinity for asialoglycoprotein receptor (ASGPR) overexpressed by human hepatoma HepG2 cells. MTX-PL/PBAE/pEGFP nanoparticles realized the efficient transfection of pEGFP in HepG2 cells and exhibited significant inhibitory effect on the cell proliferation. In HepG2 tumor-bearing nude mice, MTX-PL/PBAE/pEGFP nanoparticles were mainly distributed in the tumor after 24 h postintravenous injection. Altogether, this novel codelivery system with a strong hepatoma-targeting property achieved simultaneous delivery of gene and chemotherapy agent into tumor at both cellular and animal levels.

Entities:  

Keywords:  chemotherapy agent; gene; hepatoma; poly(β-amino) ester; pullulan

Mesh:

Substances:

Year:  2014        PMID: 25289563     DOI: 10.1021/am504203x

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  6 in total

Review 1.  Non-viral nucleic acid containing nanoparticles as cancer therapeutics.

Authors:  Kristen L Kozielski; Yuan Rui; Jordan J Green
Journal:  Expert Opin Drug Deliv       Date:  2016-06-06       Impact factor: 6.648

2.  Chitosan nanoparticle-mediated co-delivery of shAtg-5 and gefitinib synergistically promoted the efficacy of chemotherapeutics through the modulation of autophagy.

Authors:  Yan Zheng; Chang Su; Liang Zhao; Yijie Shi
Journal:  J Nanobiotechnology       Date:  2017-04-11       Impact factor: 10.435

3.  Pullulan-coated phospholipid and Pluronic F68 complex nanoparticles for carrying IR780 and paclitaxel to treat hepatocellular carcinoma by combining photothermal therapy/photodynamic therapy and chemotherapy.

Authors:  Dan Wang; Sipei Zhang; Tao Zhang; Guoyun Wan; Bowei Chen; Qingqing Xiong; Jie Zhang; Wenxue Zhang; Yinsong Wang
Journal:  Int J Nanomedicine       Date:  2017-12-05

4.  Enhanced transfection of a macromolecular lignin-based DNA complex with low cellular toxicity.

Authors:  Yoon Khei Ho; Dan Kai; Geraldine Xue En Tu; G Roshan Deen; Heng Phon Too; Xian Jun Loh
Journal:  Biosci Rep       Date:  2018-11-30       Impact factor: 3.840

5.  Co-delivery of doxorubicin and shRNA of Beclin1 by folate receptor targeted pullulan-based multifunctional nanomicelles for combinational cancer therapy.

Authors:  Lili Chen; Ming Qian; Liuwei Zhang; Jing Xia; Yongming Bao; Jingyun Wang; Lianying Guo; Yachen Li
Journal:  RSC Adv       Date:  2018-05-15       Impact factor: 4.036

6.  Methotrexate Nanoparticles Prepared with Codendrimer from Polyamidoamine (PAMAM) and Oligoethylene Glycols (OEG) Dendrons: Antitumor Efficacy in Vitro and in Vivo.

Authors:  Yanna Zhao; Yifei Guo; Ran Li; Ting Wang; Meihua Han; Chunyan Zhu; Xiangtao Wang
Journal:  Sci Rep       Date:  2016-07-08       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.